Lipin-1 deficiency deteriorates defect of fatty acid β-oxidation and lipid-related kidney damage in diabetic kidney disease

International Diabetes Federation (2017) Diabetes facts and figures. Available at https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Fioretto, 2007, Histopathology of diabetic nephropathy, Semin Nephrol, 27, 195, 10.1016/j.semnephrol.2007.01.012 Bonventre, 2012, Can we target tubular damage to prevent renal function decline in diabetes?, Semin Nephrol, 32, 452, 10.1016/j.semnephrol.2012.07.008 Jefferson, 2008, Proteinuria in diabetic kidney disease: a mechanistic viewpoint, Kidney Int, 74, 22, 10.1038/ki.2008.128 Kang, 2015, Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development, Nat Med, 21, 37, 10.1038/nm.3762 Herman-Edelstein, 2014, Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy, J Lipid Res, 55, 561, 10.1194/jlr.P040501 Wahl, 2016, Systemic and renal lipids in kidney disease development and progression, Am J Physiol Renal Physiol, 310, F433, 10.1152/ajprenal.00375.2015 Cheung, 2021, Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease, Kidney Int, 99, 559, 10.1016/j.kint.2020.10.026 2018, 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018, Diabetes Care, 41, S13, 10.2337/dc18-S002 Perez-Marti, 2022, Reducing lipid bilayer stress by monounsaturated fatty acids protects renal proximal tubules in diabetes, Elife, 11, e74391, 10.7554/eLife.74391 Garofalo, 2017, A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population, Kidney Int, 91, 1224, 10.1016/j.kint.2016.12.013 Sandino, 2021, Which patients with obesity are at risk for renal disease?, Nephron, 145, 595, 10.1159/000513868 de Vries, 2014, Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease, Lancet Diabetes Endocrinol, 2, 417, 10.1016/S2213-8587(14)70065-8 Arici, 2003, Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma, J Am Soc Nephrol, 14, 17, 10.1097/01.ASN.0000042167.66685.EA Moorhead, 1982, Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease, Lancet, 2, 1309, 10.1016/S0140-6736(82)91513-6 Srivastava, 2018, SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis, Cell Death Dis, 9, 997, 10.1038/s41419-018-1057-0 Jao, 2019, ATF6alpha downregulation of PPARalpha promotes lipotoxicity-induced tubulointerstitial fibrosis, Kidney Int, 95, 577, 10.1016/j.kint.2018.09.023 Wanner, 2007, Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk, J Ren Nutr, 17, 75, 10.1053/j.jrn.2006.10.012 Srivastava, 2014, Lipid mediators in diabetic nephropathy, Fibrogenesis Tissue Repair, 7, 12, 10.1186/1755-1536-7-12 Un Nisa, 2022, Lipin-1 stability and its adipogenesis functions are regulated in contrasting ways by AKT1 and LKB1, J Cell Commun Signal, 10.1007/s12079-022-00708-9 Song, 2020, Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy, Nat Commun, 11, 5842, 10.1038/s41467-020-19694-w Peterfy, 2001, Lipodystrophy in the FLD mouse results from mutation of a new gene encoding a nuclear protein, lipin, Nat Genet, 27, 121, 10.1038/83685 Peterfy, 1999, Genetic, physical, and transcript map of the FLD region on mouse chromosome 12, Genomics, 62, 436, 10.1006/geno.1999.6023 Phan, 2005, Lipin, a lipodystrophy and obesity gene, Cell Metab, 1, 73, 10.1016/j.cmet.2004.12.002 Reue, 2008, Thematic review series: glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism, J Lipid Res, 49, 2493, 10.1194/jlr.R800019-JLR200 Finck, 2006, Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway, Cell Metab, 4, 199, 10.1016/j.cmet.2006.08.005 Schilke, 2020, Macrophage-associated lipin-1 promotes beta-oxidation in response to proresolving stimuli, Immunohorizons, 4, 659, 10.4049/immunohorizons.2000047 Yin, 2014, Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver, Gastroenterology, 146, 801, 10.1053/j.gastro.2013.11.008 Woroniecka, 2011, Transcriptome analysis of human diabetic kidney disease, Diabetes, 60, 2354, 10.2337/db10-1181 Jonker, 2018, Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention, Nephrol Dial Transplant, 33, 224, 10.1093/ndt/gfx243 Vallon, 2020, The tubular hypothesis of nephron filtration and diabetic kidney disease, Nat Rev Nephrol, 16, 317, 10.1038/s41581-020-0256-y Csaki, 2014, Lipin-1 and lipin-3 together determine adiposity in vivo, Mol Metab, 3, 145, 10.1016/j.molmet.2013.11.008 Croce, 2007, Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss, Diabetes, 56, 2395, 10.2337/db07-0480 Yao-Borengasser, 2006, Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation, Diabetes, 55, 2811, 10.2337/db05-1688 Zhang, 2019, Mangiferin improved palmitate-induced-insulin resistance by promoting free fatty acid metabolism in HepG2 and C2C12 Cells via PPARalpha: mangiferin improved insulin resistance, J Diabetes Res, 2019, 10.1155/2019/2052675 Sanchez-Alegria, 2021, Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells, FASEB J, 35, e21712, 10.1096/fj.202100243R Han, 2020, RNA-sequencing analysis reveals the potential contribution of lncRNAs in palmitic acid-induced insulin resistance of skeletal muscle cells, Biosci Rep, 40, 10.1042/BSR20192523 Bouatra, 2013, The human urine metabolome, PLoS One, 8, e73076, 10.1371/journal.pone.0073076 Gonzalez, 2012, Regulation of lipin1 by nutritional status, adiponectin, sex and pituitary function in rat white adipose tissue, Physiol Behav, 105, 777, 10.1016/j.physbeh.2011.10.016 Marable, 2020, Hnf4a is required for the development of Cdh6-expressing progenitors into proximal tubules in the mouse kidney, J Am Soc Nephrol, 31, 2543, 10.1681/ASN.2020020184 Sohn, 2017, Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy, Am J Physiol Renal Physiol, 312, F323, 10.1152/ajprenal.00596.2015 Kim, 2013, Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice, Diabetologia, 56, 204, 10.1007/s00125-012-2747-2 Martin, 2022, Dietary restriction and medical therapy drive PPARalpha-regulated improvements in early diabetic kidney disease in male rats, Clin Sci (Lond), 136, 1485, 10.1042/CS20220205 Sas, 2016, Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications, JCI Insight, 1, e86976, 10.1172/jci.insight.86976 Liu, 2022, Twist1 downregulation of PGC-1alpha decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis, Theranostics, 12, 3758, 10.7150/thno.71722 Panov, 2022, Long-chain and medium-chain fatty acids in energy metabolism of murine kidney mitochondria, Int J Mol Sci, 24 Sun, 2018, Berberine protects against palmitate-induced apoptosis in tubular epithelial cells by promoting fatty acid oxidation, Med Sci Monit, 24, 1484, 10.12659/MSM.908927 Khan, 2020, Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression, JCI Insight, 5, 10.1172/jci.insight.136845 Hong, 2014, Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1alpha in db/db mice, PLoS One, 9, e96147, 10.1371/journal.pone.0096147 Grove, 2014, Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles, J Lipid Res, 55, 1375, 10.1194/jlr.M049189 Miserez, 2002, Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia, Atherosclerosis, 164, 15, 10.1016/S0021-9150(01)00762-6 Peterson, 2011, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway, Cell, 146, 408, 10.1016/j.cell.2011.06.034 Romani, 2019, Extracellular matrix mechanical cues regulate lipid metabolism through Lipin-1 and SREBP, Nat Cell Biol, 21, 338, 10.1038/s41556-018-0270-5 Rashid, 2019, Lipin1 deficiency causes sarcoplasmic reticulum stress and chaperone-responsive myopathy, EMBO J, 38, e99576, 10.15252/embj.201899576 Zhang, 2014, Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle, Cell Metab, 20, 267, 10.1016/j.cmet.2014.05.003 Chambers, 2021, Myocardial Lipin 1 knockout in mice approximates cardiac effects of human LPIN1 mutations, JCI Insight, 6, 10.1172/jci.insight.134340 Legendre, 2018, Cardiac function and exercise adaptation in 8 children with LPIN1 mutations, Mol Genet Metab, 123, 375, 10.1016/j.ymgme.2017.12.429 Harris, 2007, Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1, J Biol Chem, 282, 277, 10.1074/jbc.M609537200